<code id='269E5AE46A'></code><style id='269E5AE46A'></style>
    • <acronym id='269E5AE46A'></acronym>
      <center id='269E5AE46A'><center id='269E5AE46A'><tfoot id='269E5AE46A'></tfoot></center><abbr id='269E5AE46A'><dir id='269E5AE46A'><tfoot id='269E5AE46A'></tfoot><noframes id='269E5AE46A'>

    • <optgroup id='269E5AE46A'><strike id='269E5AE46A'><sup id='269E5AE46A'></sup></strike><code id='269E5AE46A'></code></optgroup>
        1. <b id='269E5AE46A'><label id='269E5AE46A'><select id='269E5AE46A'><dt id='269E5AE46A'><span id='269E5AE46A'></span></dt></select></label></b><u id='269E5AE46A'></u>
          <i id='269E5AE46A'><strike id='269E5AE46A'><tt id='269E5AE46A'><pre id='269E5AE46A'></pre></tt></strike></i>

          Home / fashion / leisure time

          leisure time


          leisure time

          author:explore    Page View:28
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In